Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): A cluster randomized trial

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Van Riet, Evelien E S ^a   Hoes, Arno W ^a   Limburg, Alexander ^b   van der Hoeven, Henk ^b   Landman, Marcel A J ^a   Rutten, Frans H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Diakonessenhuis Zeist   (Netherlands)

Author keywords

Cluster randomized trial; Diagnosis; Elderly; Heart failure; Primary care; Treatment

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; THIAZIDE DIURETIC AGENT;

AGED; ANAMNESIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSPNEA; ELECTROCARDIOGRAM; ELECTRONIC MEDICAL RECORD; FEMALE; FUNCTIONAL STATUS; GENERAL PRACTITIONER; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SOCIETY; NETHERLANDS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STRATEGIC PLANNING; VERY ELDERLY; WALKING SPEED;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CLINICAL PROTOCOLS; DYSPNEA; ECHOCARDIOGRAPHY; EDUCATION, MEDICAL, CONTINUING; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; PEPTIDE FRAGMENTS; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; RECOGNITION (PSYCHOLOGY); RESEARCH DESIGN; SINGLE-BLIND METHOD; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84892168827     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-1     Document Type: Article

References (31)

1. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, et al. Prevention of heart failure: a scientific statement from the American heart association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 2008, 117:2544-2565. 10.1161/CIRCULATIONAHA.107.188965, 18391114.
2. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402. 10.1056/NEJMoa020265, 12409541.
3. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004, 292:344-350. 10.1001/jama.292.3.344, 15265849.
4. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology; developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur J Heart Fail 2008, 10:933-989. 10.1016/j.ejheart.2008.08.005, 18826876.
5. Paulus WJ. Novel strategies in diastolic heart failure. Heart 2010, 96:1147-1153. 10.1136/hrt.2009.169052, 20610461.
6. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259. 10.1056/NEJMoa052256, 16855265.
7. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007, 93:1137-1146. 10.1136/hrt.2003.025270, 1955040, 17699180.
8. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991, 12:315-321.
9. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med 1993, 86:17-23.
10. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005, 26:1887-1894. 10.1093/eurheartj/ehi291, 15860516.
11. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international survey. Lancet 2002, 360:1631-1639. 10.1016/S0140-6736(02)11601-1, 12457785.
12. Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003, 5:337-344. 10.1016/S1388-9842(03)00050-3, 12798832.
13. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 2003, 5:247-252. 10.1016/S1388-9842(02)00244-1, 12798821.
14. Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009, 39:495-501. 10.1111/j.1445-5994.2008.01880.x, 19732197.
15. Spertus J, Peterson E, Conard MW, Heidenreich PA, Krumholz HM, Jones P, et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 2005, 150:707-715. 10.1016/j.ahj.2004.12.010, 16209970.
16. Lamberts H, Oskam SK, Okkes IM. the clinical relationship between symptoms and the final diagnosis in general practice, determined by means of posterior probabilities calculated on the basis of the transition project. Ned Tijdschr Geneeskd 2005, 149:2566-2572.
17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology: developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803-869.
18. Rose GA, Blackburn H. Cardiovascular survey methods 1982, Geneva: World Health Organisation.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463. 10.1016/j.echo.2005.10.005, 16376782.
20. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009, 22:107-133. 10.1016/j.echo.2008.11.023, 19187853.
21. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.
22. Rutten FH, Walma EP, Kruizinga GI, Bakx HCA, Van Lieshout J. NHG-standaard hartfalen. Huisarts Wet 2005, 48(2):64-76.
23. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European society of cardiology. Eur Heart J 2007, 28:2539-2550. 10.1093/eurheartj/ehm037, 17428822.
24. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613-618. 10.1161/01.CIR.55.4.613, 138494.
25. Pollentier B, Irons SL, Benedetto CM, Dibenedetto AM, Loton D, Seyler RD, et al. Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J 2010, 21:13-21.
26. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998, 51:1055-1068. 10.1016/S0895-4356(98)00097-3, 9817123.
27. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263. 10.1097/00005650-199303000-00006, 8450681.
28. EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. EuroQol Group.
29. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37:53-72. 10.1016/0168-8510(96)00822-6, 10158943.
30. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the dutch manual for costing in economic evaluations. Pharmacoeconomics 2002, 20:443-454. 10.2165/00019053-200220070-00002, 12093300.
31. Health Insurance Council Dutch guidelines for pharmacoeconomic research 1999, Amstelveen: Ziekenfondsraad, Health Insurance Council.